Bulk and single-cell characterisation of the immune heterogeneity of atherosclerosis identifies novel targets for immunotherapy.

Xiong, Jie; Li, Zhaoyue; Tang, Hao; Duan, Yuchen; Ban, Xiaofang; Xu, Ke; Guo, Yutong; Tu, Yingfeng

Xiong, Jie; Li, Zhaoyue; Tang, Hao; Duan, Yuchen; Ban, Xiaofang; Xu, Ke; Guo, Yutong; Tu, Yingfeng.

Afiliación

Xiong J; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Li Z; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Tang H; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Duan Y; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Ban X; Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Xu K; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Guo Y; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Tu Y; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China. tyfdoctor@163.com.

BMC Biol ; 21(1): 46, 2023 02 28.

Article en En | MEDLINE | ID: mdl-36855107

Asunto(s)

Aterosclerosis; Linfocitos T CD8-positivos; Inmunoterapia; Humanos; Aterosclerosis/genética; Aterosclerosis/terapia; Transporte Biológico

Palabras clave

Atherosclerosis; Heterogeneity; Immune cells; Immunotherapy; Single-cell RNA sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Aterosclerosis / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BMC Biol Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google